Stock Option

HANALL BIOPHARMA CO.,LTD

009420·KOSPI·9 grantsAmendments merged

Shares granted, cumulative
714,480shares
Next lockup release
—

Against the share price

At the 2026-08-18 close
KRW
-1.68%
Shares with a reason to exercise
515,000 shares
0.99% of shares outstanding
Sellable right now
515,000 shares
100% of the shares with a reason to exercise
Unrealized paper gain (to the employees)
₩18.2B

Potential dilution

0.99%Against the 15% cap

Shares by strike price

  • ₩58,700Latest price
  • ₩32,600105K shares
  • ₩23,81025K shares
  • ₩23,363200K shares
  • ₩19,58310K shares
  • ₩18,55875K shares
  • ₩17,846100K shares

Below the line (strike < Latest price) sits above the strike price: 515K shares, 100% of the shares still inside their exercise window.

Exercise deadline within a yearD-69Earliest deadline 2026-10-28

The paper gain on 330,000 shares sitting above the strike price — ₩10.7B — disappears unless they are exercised by the deadline. Among the options whose lockup has ended, this is the part whose timing is pinned down.

See every approaching deadline

Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.

Share price vs. strike price

A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.

Close ₩58,7002025-08-14 ~ 2026-08-18
  • Strike ₩23,363200K sharesabove
  • Strike ₩32,600105K sharesabove
  • Strike ₩17,846100K sharesabove
  • Strike ₩18,55875K sharesabove

Recipients by role

615KShares granted
  • Registered director4 people49%
  • Unregistered officer3 people18%
  • Employee27 people33%

Sorted from the relation text written in the filings (34 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers.

Shares granted by year

27K
72K
205K
225K
85K
100K
'17
'18
'19
'20
'21
'22
'23

Cumulative grants per recipient

3 named · 7 withheld
Largest holder박승국Registered director
Top holder 38.8%Top 3 63.1%
RecipientShares, cumulativePaper gain
200,00038.8%₩7.1B
100,00019.4%₩4.1B
25,0004.9%₩872.3M
190,00036.9%₩6.1B

Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.

Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.